Growth Metrics

Oculis Holding AG (OCS) Cash & Equivalents Growth (3y) (2024 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -51.77%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 24.73%
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 4.69%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 13.33%
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -16.07%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -8.88%
8 Evaxion A 65.12 Bn 65.10 Bn - 21.66%
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 36.53%
10 Oculis Holding AG 24.51 Bn 24.21 Bn - 69.33%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 69.33%
Dec 31, 2025 70.48%
Sep 30, 2025 6.61%
Jun 30, 2025 17.34%
Dec 31, 2024 -14.26%